• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-200
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pancreatitis (4481); Unspecified Hepatic or Biliary Problem (4493)
Event Date 11/01/2022
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article https://doi.Org/10.1016/j.Gie.2022.10.038, provided for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus medical systems corp.(omsc) received a literature titled "endoscopic ultrasound-guided antegrade stent placement in patients with failed ercp as a modality of preoperative and palliative biliary drainage." literature summary this retrospective review study aims to assess the outcomes of eus-guided antegrade biliary drainage (eus-ag) in patients with failed ercp or inaccessible papilla in both the palliative setting and as a modality of preoperative biliary drainage.A total of 54 patients were included.Most common primary cancer was pancreatic cancer in 42.1% (23/54) patients.Indication was palliative in 34 (62.9%) patients and pbd in 20 (37%) patients.Level of block was distal in 35 (64.8%) and proximal in 19 (35.1%) patients.Technical success of eus-ag was 88.7% (47/53).Clinical success was seen in 95.7% (45/47) patients.No severe adverse events were reported related to the procedure.Out of 20 patients who underwent endoscopic-ultrasound biliary drainage (eus-bd) as a modality of pbd, 19 had a distal cbd stricture, while one had a bismuth type i hilar block.Technical success was achieved in 19 (95%) patients.Eus-ag is safe and "effective" after failed ercp in both preoperative and palliative setting.Type of adverse events/number of patients: event1: severe intrahepatic cholestasis - 2 patients, event2: postprocedure cholecystitis - 1 patient, event3: mild pancreatitis - 1 patient, event4: self-limiting pneumoperitoneum - 2 patients, event5: died of advanced disease within 3 months - 7 patients, event6: expired due to pulmonary thromboembolism - 1 patient event7: leak at the pancreaticojejunostomy site - 1 patient, event8: bleeding in the surgical bed needing re-exploration.Despite controlling the bleeding, the patient subsequently developed multiorgan dysfunction and expired - 1 patient, this literature article requires 2 reports.The related patient identifiers are as follows: (b)(6) reports the device gf-uct180 for events 2, 7, (b)(6) reports the device gf-uct180 for events 6, 8.This medwatch report is for (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and correction to the initial with information inadvertently left out.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Event Description
Other relevant patient identifiers as follows: (b)(6) (g-260-2545a).(b)(6) (sme-210p-10060).(b)(6) (tjf-260v).(b)(6) (jf-240).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key17242620
MDR Text Key318439382
Report Number9610595-2023-09588
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K954451
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-200
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/05/2023
Initial Date FDA Received06/30/2023
Supplement Dates Manufacturer Received07/07/2023
Supplement Dates FDA Received08/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-